Oxalis Leaf

Oxalis leaf is rich in flavonoid C-glycosides—vitexin, isovitexin, and orientin—along with phenolic acids that exhibit potent DPPH/ABTS radical scavenging, anti-acetylcholinesterase, and anti-tyrosinase activities, as confirmed by HPLC-DAD-ESI/MS profiling of Oxalis pes-caprae (PMID 28627294). Additional research has identified phytotoxic aromatic constituents in Oxalis species (PMID 19353540), endophytic fungi with antimicrobial potential from Oxalis latifolia (PMID 38404537), and biogenic ZnO nanoparticles synthesized from Oxalis stricta leaf extract demonstrating significant in vitro cytotoxicity against colon cancer cells via apoptotic pathways (PMID 40614025).

Origin & History

Oxalis (Oxalis spp.), commonly known as wood sorrel, is a genus of flowering plants found across tropical and temperate regions worldwide. Characterized by its clover-like leaves and tart flavor, it is valued in functional nutrition for its rich antioxidant content and traditional use in detoxification.

Historical & Cultural Context

Oxalis Leaf has been a symbol of prosperity and resilience in various cultures, traditionally used for digestive support, detoxification, and fever relief in South American, African, and Ayurvedic medicine. It is celebrated for its adaptability and association with renewal.

Health Benefits

- **Supports immune resilience**: by providing vitamin C and flavonoids that enhance cellular defense.
- **Promotes digestive health**: through its mucilage and fiber content, aiding gut motility.
- **Enhances cardiovascular wellness**: by delivering essential minerals like potassium and antioxidant flavonoids.
- **Aids detoxification processes,**: supporting the body's natural cleansing pathways.
- **Contributes to cognitive**: clarity by reducing oxidative stress and supporting neural function.
- **Boosts skin vitality**: through antioxidant protection and support for cellular regeneration.

How It Works

The principal flavonoid C-glycosides in Oxalis leaf—vitexin, isovitexin, and orientin—function as dual-mode antioxidants via hydrogen-atom transfer (HAT) and single-electron transfer (SET) mechanisms, donating electrons from phenolic hydroxyl groups on their A- and B-rings to neutralize DPPH and ABTS radicals and interrupt lipid peroxidation cascades (PMID 28627294). Anti-acetylcholinesterase activity arises from competitive binding of these C-glycosides to the catalytic anionic site (CAS) and peripheral anionic site (PAS) of AChE, inhibiting acetylcholine hydrolysis and thereby supporting cholinergic neurotransmission. Anti-tyrosinase effects are mediated by chelation of the di-copper active-site ions in tyrosinase by ortho-dihydroxyl groups on orientin's B-ring, suppressing melanin biosynthesis at the L-DOPA oxidation step. Additionally, ZnO nanoparticles synthesized using Oxalis stricta leaf phytochemicals have been shown to induce apoptosis in HCT-116 colon cancer cells, likely through reactive oxygen species (ROS)-mediated mitochondrial membrane depolarization (PMID 40614025).

Scientific Research

Gaspar et al. (2018) in Natural Product Research used HPLC-DAD-ESI/MS to profile Oxalis pes-caprae L. leaf extract, identifying vitexin, isovitexin, and orientin as dominant flavonoid C-glycosides with potent DPPH and ABTS radical scavenging, anti-acetylcholinesterase (AChE), and anti-tyrosinase bioactivities (PMID 28627294). Chandramohan et al. (2025) in Biometals demonstrated that biogenic ZnO nanoparticles synthesized from Oxalis stricta leaf extract displayed significant in vitro cytotoxicity against HCT-116 colon cancer cells, supported by in silico molecular docking studies (PMID 40614025). DellaGreca et al. (2009) in Chemistry & Biodiversity isolated phytotoxic aromatic constituents—including chromone and naphthalenone derivatives—from Oxalis pes-caprae, establishing the species' broader bioactive chemical diversity (PMID 19353540). Hussein et al. (2024) in Saudi Journal of Biological Sciences reported that endophytic fungi isolated from Oxalis latifolia exhibited notable antimicrobial activity against selected human pathogens, suggesting the plant harbors synergistic bioactive microorganisms (PMID 38404537).

Clinical Summary

In vitro studies on Oxalis latifolia demonstrate significant antioxidant activity with DPPH inhibition of 66.8% and ABTS inhibition of 67.7%. Molecular docking studies show bioactive compounds exhibit binding affinities to p21 protein comparable to cisplatin-quercetin for anticancer potential. However, human clinical trials are extremely limited, with most evidence derived from laboratory and animal studies. The current research base lacks adequate human safety and efficacy data.

Nutritional Profile

- Vitamins: Vitamin C
- Minerals: Potassium, Magnesium, Calcium
- Phytochemicals/Bioactives: Flavonoids (Quercetin, Kaempferol), Oxalates, Mucilage

Preparation & Dosage

- Fresh Leaf: Consume 1–2g daily, typically brewed as a tea or incorporated into culinary dishes.
- Powdered Extract: Take 500–1,000mg daily, often found in detox teas, immune supplements, or functional foods.

Synergy & Pairings

Role: Polyphenol/antioxidant base
Intention: Cardio & Circulation
Primary Pairings: - Lemongrass (Cymbopogon citratus)
- Turmeric (Curcuma longa)
- Hibiscus (Hibiscus sabdariffa)
- Ginger (Zingiber officinale)

Safety & Interactions

Oxalis leaves contain significant levels of soluble oxalates (oxalic acid and potassium oxalate), which can bind dietary calcium to form insoluble calcium oxalate crystals; excessive consumption may increase the risk of kidney stone formation in susceptible individuals and exacerbate hyperoxaluria. Persons taking anticoagulant medications (e.g., warfarin) should exercise caution, as vitamin K-containing greens may modulate warfarin efficacy, and high oxalate intake can alter mineral absorption profiles. Although no direct CYP450 interaction data for Oxalis leaf flavonoids have been published, structurally related C-glycosyl flavones such as vitexin have shown in vitro inhibition of CYP3A4 and CYP2C9 at high concentrations, warranting caution in patients on substrates of these enzymes (e.g., statins, NSAIDs). Pregnant and breastfeeding women should consult a healthcare provider before use, as safety data in these populations remain insufficient.